Cargando…

PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease

Detalles Bibliográficos
Autores principales: Iwata, Nobuhisa, Asai, Masashi, Hatta, Daisuke, Honda, Mikako, Hori, Yuma, Kinoshita, Momoka, Kuroda, Naotaka, Ohyama, Kaname, Shirotani, Keiro, Tanaka, Takashi, Watanabe, Kaori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616913/
http://dx.doi.org/10.1093/ijnp/pyw044.579
_version_ 1783266894924480512
author Iwata, Nobuhisa
Asai, Masashi
Hatta, Daisuke
Honda, Mikako
Hori, Yuma
Kinoshita, Momoka
Kuroda, Naotaka
Ohyama, Kaname
Shirotani, Keiro
Tanaka, Takashi
Watanabe, Kaori
author_facet Iwata, Nobuhisa
Asai, Masashi
Hatta, Daisuke
Honda, Mikako
Hori, Yuma
Kinoshita, Momoka
Kuroda, Naotaka
Ohyama, Kaname
Shirotani, Keiro
Tanaka, Takashi
Watanabe, Kaori
author_sort Iwata, Nobuhisa
collection PubMed
description
format Online
Article
Text
id pubmed-5616913
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56169132017-11-27 PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease Iwata, Nobuhisa Asai, Masashi Hatta, Daisuke Honda, Mikako Hori, Yuma Kinoshita, Momoka Kuroda, Naotaka Ohyama, Kaname Shirotani, Keiro Tanaka, Takashi Watanabe, Kaori Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616913/ http://dx.doi.org/10.1093/ijnp/pyw044.579 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Iwata, Nobuhisa
Asai, Masashi
Hatta, Daisuke
Honda, Mikako
Hori, Yuma
Kinoshita, Momoka
Kuroda, Naotaka
Ohyama, Kaname
Shirotani, Keiro
Tanaka, Takashi
Watanabe, Kaori
PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title_full PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title_fullStr PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title_full_unstemmed PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title_short PT579. Disease-modifying therapy through enhancement of neuronal Aß-degrading enzyme neprilysin activity for Alzheimer’s disease
title_sort pt579. disease-modifying therapy through enhancement of neuronal aß-degrading enzyme neprilysin activity for alzheimer’s disease
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616913/
http://dx.doi.org/10.1093/ijnp/pyw044.579
work_keys_str_mv AT iwatanobuhisa pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT asaimasashi pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT hattadaisuke pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT hondamikako pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT horiyuma pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT kinoshitamomoka pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT kurodanaotaka pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT ohyamakaname pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT shirotanikeiro pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT tanakatakashi pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease
AT watanabekaori pt579diseasemodifyingtherapythroughenhancementofneuronalaßdegradingenzymeneprilysinactivityforalzheimersdisease